高MELD 3.0评分并非减重手术的绝对禁忌证
该研究利用NSQIP 2017-2019及2021-2022数据,纳入17,866例接受Roux-en-Y胃旁路术或袖状胃切除术的患者,计算每例患者的MELD 3.0评分并分析死亡率。观察到的绝对死亡率在MELD 3.0≤18时低于1%;167例MELD 3.0>20的患者中仅1例死亡。结论提示高MELD 3.0评分并非减重手术的绝对禁忌证。
要点
- MELD 3.0≤18时减重手术观察死亡率低于1%。
- MELD 3.0>20的167例患者中仅1例死亡。
- MELD 3.0>19后模型预测能力下降,需个体化评估。
核心结论
- 高MELD 3.0评分不是减重手术的绝对禁忌证,部分高分患者可安全手术。
研究设计与样本
- 回顾性队列研究,使用NSQIP 2017-2019及2021-2022数据,纳入17,866例Roux-en-Y胃旁路术或袖状胃切除术患者。
主要发现
- MELD 3.0≤18时绝对观察死亡率低于1%。
- 167例MELD 3.0>20患者中仅1例死亡。
- 最佳拟合线r²=0.903,预测死亡率在MELD 3.0=13时低于1%,MELD 3.0=18时低于4%。
- MELD 3.0>19时因数据不足模型预测能力下降。
临床怎么用
- 对高MELD 3.0评分患者不应仅凭评分拒绝减重手术,应结合个体情况评估手术风险与获益。
局限性
- MELD 3.0>19时数据不足,模型预测能力下降。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: MELD 3.0 is a composite score used to predict mortality due to liver disease. Obesity is increasingly linked to liver disease and cirrhosis. Bariatric surgery is the most effective and durable method of managing morbid obesity and significantly improves many associated comorbid conditions, yet it is not without risk. Determining a reasonable risk profile for bariatric surgery is a complex decision made more difficult by lack of data regarding morbidity and mortality. METHODS: We used data from the National Surgical Quality Improvement Program (NSQIP) from 2017-2019 to 2021-2022. Patients who underwent Roux-en-Y gastric bypass or sleeve gastrectomy were included. Each patient's MELD 3.0 score was calculated. The primary outcome was mortality, calculated at each MELD 3.0 score. A line of best fit was constructed and used to calculate expected mortality rates for each MELD 3.0. RESULTS: We identified 17,866 patients. Absolute observed mortality rates remained under 1% up to a MELD 3.0 of 18. Additionally, 167 patients with a MELD 3.0 greater than 20 were identified with only 1 mortality. The line of best fit showed an r2 value of 0.903 with predicted mortality remaining below 1% at a MELD 3.0 of 13, and below 4% at MELD 3.0 of 18. Due to insufficient data, the predictiveness of the model decreased above a MELD 3.0 of 19. CONCLUSION: Our data suggests that there are specific patients with seemingly prohibitive MELD 3.0 scores who are able to safely undergo bariatric surgery. A high MELD 3.0 score is not an absolute contraindication for bariatric surgery. Further research exploring safe patient selection criteria could allow bariatric surgeons to identify a group of patients that had previously been thought too high-risk for bariatric surgery, but who could benefit immensely from the weight loss and improvement in comorbid conditions that bariatric surgery provides.
引用
- Flippin JA, Kang S, Farman RO, et al. High MELD 3.0 score is not an absolute contraindication to bariatric surgery. Surg Endosc. 2025. PMID: 40770512. doi:10.1007/s00464-025-11940-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。